US Pharma MarketingThe post Tenax Therapeutics’ stock crashes on Phase III trial failure appeared first on Clinical Trials Arena.
Tenax Therapeutics’ stock crashes on Phase III trial failure
Despite the miss, a subgroup of patients with more severe disease showed more meaningful benefit data Tenax plans to submit to the FDA and EMA. The post Tenax Therapeutics’ stock crashes on Phase III trial failure appeared first on Clinical Trials Arena .
Despite the miss, a subgroup of patients with more severe disease showed more meaningful benefit - data Tenax plans to submit to the FDA and EMA.
Source: Clinical Trials Arena